Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems

International Journal of Pharmaceutics

Volumn 309, Issue 1-2, 2006, Pages 129-138

  Ammar, H O ^a   Salama, H A ^a   Ghorab, M ^b   Mahmoud, A A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Complexation; Cyclodextrins; Glimepiride; Water soluble polymers

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CYCLODEXTRIN; GLIMEPIRIDE; GLUCOSE; MACROGOL 4000; POLYMER;

ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; DIABETES MELLITUS; DISSOLUTION; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG SOLUBILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC LOAD; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PHYSICAL PHASE; PRIORITY JOURNAL; RAT; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; BETA-CYCLODEXTRINS; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; HYPOGLYCEMIC AGENTS; MALE; POLYETHYLENE GLYCOLS; POLYMERS; RATS; RATS, WISTAR; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SULFONYLUREA COMPOUNDS; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY; WATER;

EID: 31144433828     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.11.024     Document Type: Article

References (44)

1. S. Aggarwal, P.N. Singh, and B. Mishra Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin- hydroxypropylmethylcellulose complexes Pharmazie 57 2002 191 193
2. C. Albertson, C. Davis, J. Ellison, and C. Chu Clinical evaluation of a new miniaturized biosensor for self-monitoring of blood glucose Clin. Chem. 44 1998 2056 2057
3. B.J. Aungst Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J. Pharm. Sci. 82 1993 979 987
4. M.L. Calabrò, S. Tommasini, P. Donato, D. Raneri, R. Stancanelli, P. Ficarra, R. Ficarra, C. Costa, S. Catania, C. Rustichelli, and G. Gamberini J. Pharm. Biomed. Anal. 35 2004 365
5. O.I. Corrigan, and T. Stanley Mechanism of drug dissolution enhancement from β-cyclodextrin-drug systems J. Pharm. Pharmacol. 34 1982 621 626
6. E.M.M. Del Valle Cyclodextrins and their uses: a review Process Biochem. 39 2004 1033 1046
7. C.M. Fernandes, M.T. Vieira, and F. Veigaa Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds Eur. J. Pharm. Sci. 15 2002 79 88
8. A. Frick, H. Moller, and E. Wirbitzki Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin Eur. J. Pharm. Biopharm. 46 1998 305 311
9. H. Fridriksdottir, T. Loftsson, and E. Stefansson Formulation and testing of methazolamide cyclodextrin eye drop solutions J. Cont. Rel. 44 1997 95 99
10. H. Fujita, T. Ooya, M. Kurisawa, H. Mori, M. Terano, and N. Yui Thermally switchable polyrotaxane as a model of stimuli-responsive supramolecules for nano-scale devices Macromol. Rapid Commun. 17 1996 509 515
11. 13C NMR investigations of anhydrous and hydrated cyclomalto- oligosaccharides: the role of water of hydration Carbohydr. Res. 166 1987 27 33
12. 1 receptor Eur. J. Pharm. 514 2005 61 67
13. K. Geinsen Special pharmacology of the new sulfonylurea glimepiride Drug Res. 38 1988 1120 1130
14. T. Higuchi, and K.A. Connors Phase solubility technique Adv. Anal. Chem. Instrum. 4 1965 117 212
15. T. Higuchi, and H. Kristiansen Binding specificity between small organic solutes in aqueous solution: classification of some solutes into two groups according to binding tendencies J. Pharm. Sci. 59 1970 1601 1608
16. M. Jug, and M. Becirevic-Lacan Influence of hydroxypropyl-β- cyclodextrin complexation on piroxicam release from buccoadhesive tablets Eur. J. Pharm. Sci. 21 2004 251 260
17. I. Kouichi, W. Masaki, N. Youhei, S. Takahiro, T. Nobuki, T. Masahiko, K. Hideyuki, Y. Kensuke, S. Masao, K. Susumu, A. Takuya, and K. Shigehiro Efficacy of glimepiride in Japanese type 2 diabetic subjects Diab. Res. Clin. Pract. 68 2005 250 257
18. M. Kurozumi, N. Nambu, and T. Nagai Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form Chem. Pharm. Bull. 23 1975 3062 3068
19. L. Ladriere, F. Malaisse-Lagae, J. Fuhlendorff, and W.J. Malaisse Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats Eur. J. Pharm. 335 1997 227 234
20. T. Loftsson, H. Fridriksdottir, A.M. Sigurdadottir, and H. Ueda The effect of water soluble polymers on drug cyclodextrin complexation Int. J. Pharm. 110 1994 169 177
21. T. Loftsson, H. Fridriksdottir, A.M. Sigurdadottir, and T.K. Gudmundsdottir The effect of water soluble polymers on the aqueous solubility of drugs Int. J. Pharm. 127 1996 293 296
22. T. Loftsson, and M.E. Brewster Cyclodextrins as pharmaceutical excipients Pharm. Technol. Eu. 9 1997 26 34
23. T. Loftsson Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water soluble polymers Pharmazie 53 1998 733 740
24. T. Loftsson, A. Magnusdottir, M. Masson, and J.F. Sigurjonsdottir Self-association and cyclodextrin solubilization of drugs J. Pharm. Sci. 91 2002 2307 2316
25. T. Loftsson, M. Masson, and M.E. Brewster Self-association of cyclodextrins and cyclodextrin complexes J. Pharm. Sci. 93 2004 1091 1099
26. A. Martin, P. Bustamante, and A.H.C. Chun Physical Pharmacy: Physical Chemical Principles in Pharmaceutical Sciences forth ed. 1993 Lippincott Williams & Wilkins pp. 260-261
27. M.B. Massimo Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience Clin. Ther. 25 2003 799 816
28. G. Mosher, and D.O. Thompson Complexation and cyclodextrins J. Swarbrick J.C. Boylan Encyclopedia of Pharmaceutical Technology 2002 Marcel Dekker New York 531
29. G. Muller, S. Wied, E. Wetekam, A. Crecelius, A. Unkelbach, and Punter Stimulation of glucose utilization in 3P3 adipocytes and rat diaphragm in vitro by the sulfonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade Biochem. Pharmacol. 48 1994 985 996
30. Y. Özkana, T. Ataya, N. Dikmena, A. Işimera, and H.Y. Aboul-Enein Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with β-cyclodextrin Pharm. Acta Helv. 74 2000 365 370
31. M.T. Pepato, E.H. Keller, A.M. Baviera, I.C. Kettelhut, and R.C. Vendarmini Anti-diabetic activity of Bauhinia forficata decoction in streptozotocin-diabetic rats J. Ethnopharmacol. 81 2002 191 197
32. L.S.S. Ribeiro, D.C. Ferreira, and F.J.P. Veiga Physicochemical investigation of the effects of water soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state Eur. J. Pharm. Sci. 20 2003 253 266
33. J.A. Ryan Compressed pellet X-ray diffraction monitoring for optimization of crystallinity in lyophlilized solids: imipenem:cilastatin sodium case J. Pharm. Sci. 75 1986 805 807
34. J. Savolainen, K. Järvinen, H. Taipale, P. Jarho, T. Loftsson, and T. Järvinen Co-administration of a water soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms Pharm. Res. 15 1998 1696 1701
35. S. Sridevi, M.G. Chary, D.R. Krishna, and P.V. Diwan Pharmacodynamic evaluation of transdermal drug delivery system of glibenclamide in rats Ind. J. Pharmacol. 32 2000 309 312
36. D. Stepensky, M. Friedman, W. Srour, I. Raz, and A. Hoffmana Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation J. Cont. Rel. 71 2001 107 115
37. K.E. Thummel Preface Adv. Drug Del. Rev. 27 1997 97 98
38. K. Uekama, N. Matsuo, F. Hirayama, H. Ichibagase, K. Arimori, K. Tsubaki, and K. Satake Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation Yakugaku Zasshi 100 1980 903 909
39. K. Uekema, Y. Horiuchi, M. Kikuchi, F. Hirayama, T. Ijitsu, and M. Ueno Enhanced dissolution and oral bioavailability of R-tocopheryl esters by dimethyl-β-cyclodextrin complexation J. Incl. Phenom. 6 1988 167 174
40. M.V.S. Varma, and R. Panchagnula Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo Eur. J. Pharm. Sci. 25 2005 445 453
41. F. Veiga, C. Fernandes, and F. Teixeira Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes Int. J. Pharm. 202 2000 165 171
42. S.G. Wagner Fundamentals of Clinical Pharmacokinetics first ed. 1975 Drug Intelligence Publications Inc. Hamilton, Illinois pp. 71
43. C.S. Winters, P. York, and P. Timmins Solid state examination of a gliclazide:beta-cyclodextrin complex Eur. J. Pharm. Sci. 5 1997 209 214
44. Q. Zhang, G. Yie, Y. Li, Q. Yang, and T. Nagai Studies on the cyclosporin A loaded stearic acid nanoparticles Int. J. Pharm. 200 2000 153 159